Literature DB >> 8240114

Negative-configuration electroretinogram in Oregon eye disease. Consistent phenotype in Xp21 deletion syndrome.

D A Pillers1, W K Seltzer, B R Powell, P N Ray, F Tremblay, G R La Roche, R A Lewis, E R McCabe, A W Eriksson, R G Weleber.   

Abstract

OBJECTIVE: To determine whether abnormal configurations on electroretinogram were a consistent finding in patients with Xp21 deletion and to characterize the associated ophthalmologic phenotype.
DESIGN: Case series.
SETTING: University hospitals and eye institutes. PATIENTS: Five patients with complex glycerol kinase deficiency (Duchenne-type or Becker's muscular dystrophy, glycerol kinase deficiency, and congenital adrenal hypoplasia) and demonstrated chromosomal deletions at Xp21. Control patients were matched by age. MAIN OUTCOME MEASURES: Clinical information was obtained from medical records. Complete ophthalmologic examinations were performed. Electroretinography was performed using a Ganzfeld technique and chloral hydrate sedation.
RESULTS: We report the clinical features and abnormal configurations on electroretinograms of five patients with complex glycerol kinase deficiency, including follow-up studies on a previously described patient. The original patient had ocular hypopigmentation; four, strabismus; two, myopia; three, astigmatism; and one, symptomatic night blindness. All had negative configurations on scotopic electroretinograms showing a reduced-amplitude B wave in the dark-adapted state.
CONCLUSIONS: Our original report suggested a diagnosis of Aland Island eye disease, which appears to be an incomplete form of congenital stationary night blindness. Linkage data place Aland Island eye disease and congenital stationary night blindness at Xp11, whereas our patients had deletions at Xp21. The phenotype reported here may represent the effects of a single gene defect or the compound effects of the Xp21 contiguous gene syndrome (complex glycerol kinase deficiency). The phenotype is referred to as Oregon eye disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8240114     DOI: 10.1001/archopht.1993.01090110124037

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  7 in total

1.  ERG phenotype of a dystrophin mutation in heterozygous female carriers of Duchenne muscular dystrophy.

Authors:  K M Fitzgerald; G W Cibis; A H Gettel; R Rinaldi; D J Harris; R A White
Journal:  J Med Genet       Date:  1999-04       Impact factor: 6.318

2.  The incidence of negative ERG in clinical practice.

Authors:  A H Koh; C R Hogg; G E Holder
Journal:  Doc Ophthalmol       Date:  2001-01       Impact factor: 2.379

Review 3.  Isolated and contiguous glycerol kinase gene disorders: a review.

Authors:  D R Sjarif; J K Ploos van Amstel; M Duran; F A Beemer; B T Poll-The
Journal:  J Inherit Metab Dis       Date:  2000-09       Impact factor: 4.982

4.  Isoflurane is an effective alternative to ketamine/xylazine/acepromazine as an anesthetic agent for the mouse electroretinogram.

Authors:  William R Woodward; Dongseok Choi; Jared Grose; Bojan Malmin; Sawan Hurst; Jiaqing Pang; Richard G Weleber; De-Ann M Pillers
Journal:  Doc Ophthalmol       Date:  2007-09-21       Impact factor: 2.379

5.  Correlation between electroretinogram findings and molecular analysis in the Duchenne muscular dystrophy phenotype.

Authors:  I De Becker; D C Riddell; J M Dooley; F Tremblay
Journal:  Br J Ophthalmol       Date:  1994-09       Impact factor: 4.638

6.  Duchenne muscular dystrophy: negative electroretinograms and normal dark adaptation. Reappraisal of assignment of X linked incomplete congenital stationary night blindness.

Authors:  H Jensen; M Warburg; O Sjö; M Schwartz
Journal:  J Med Genet       Date:  1995-05       Impact factor: 6.318

7.  Albinism: particular attention to the ocular motor system.

Authors:  Richard W Hertle
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Jul-Sep
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.